Search for dissertations about: "Growth hormone and chemotherapy"
Showing result 1 - 5 of 7 swedish dissertations containing the words Growth hormone and chemotherapy.
-
1. Childhood malignant disease and consequences for growth hormone secretion, intellectual function and cardiovascular risk
Abstract : In childhood onset growth hormone deficiency (GHD) a reduction in cardiac left ventricular mass (LVMi) and impairment of cardiac systolic function, as well as in glomerular filtration rate (GFR) has been shown. In study I, we showed that a low dose of GH treatment for 10 months resulted in increased LVMi and kidney size. READ MORE
-
2. Malignant glioma : experimental studies with an estrogen-linked cytostatic
Abstract : Malignant gliomas are the most common primary brain tumors in adults. Patients with these highly malignant tumors have an extremely poor prognosis. The situation with a highly proliferative tumor in a non-proliferating tissue should favor cytostatic treatment but so far the role of conventional chemotherapy has been adjunctive. READ MORE
-
3. A study of two major challenges in prostate cancer : effective chemo-prevention and overcoming resistance to hormonal and chemotherapy
Abstract : For men, over the course of a lifetime the risk of developing prostate cancer is 1 in 9. Both the illness itself and treatment affect quality of life in multiple aspects, including urinary problems, pain, and sexual dysfunction. READ MORE
-
4. Late effects and health-related outcomes after allogeneic hematopoietic stem cell transplantation in childhood
Abstract : Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an established treatment for many acquired or congenital disorders of the hematopoietic system. For some patients it may be the only curative option. READ MORE
-
5. Investigating the treatment of metastatic breast cancer : real-world evidence on treatment patterns, safety and efficacy
Abstract : Metastatic breast cancer is an incurable disease causing a spectrum of symptoms and leading to a continuous deterioration of performance status and quality of life. It is a heterogeneous disease, with survival being related to tumor biology and patient-related factors. READ MORE